Medicago has thorough corporate governance practices, which the Board and Management believe are essential to the success of the Company and to the enhancement of shareholder value. Medicago makes the required filings with Canadian securities regulators and accordingly, is subject to a variety of corporate governance and disclosure requirements. Medicago’s corporate governance practices meet or exceed National Instrument 58-101 "Disclosure of Corporate Governance Practices" adopted by the Canadian Securities Administrators and ensures transparency and effective governance of the Company.